Private Asset Management Lowered Exxon Mobil (XOM) Stake By $1.02 Million; Bovie Medical (BVX)’s Sentiment Is 1.21

Private Asset Management Inc decreased Exxon Mobil Corp (XOM) stake by 6.21% reported in 2017Q3 SEC filing. Private Asset Management Inc sold 12,555 shares as Exxon Mobil Corp (XOM)’s stock rose 0.21%. The Private Asset Management Inc holds 189,503 shares with $15.54M value, down from 202,058 last quarter. Exxon Mobil Corp now has $331.98B valuation. The stock decreased 1.72% or $1.37 during the last trading session, reaching $78.35. About 36.26M shares traded or 209.09% up from the average. Exxon Mobil Corporation (NYSE:XOM) has declined 9.08% since February 7, 2017 and is downtrending. It has underperformed by 25.78% the S&P500.

Bovie Medical Corporation, a medical device company, develops, makes, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company has market cap of $81.50 million. The firm provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It currently has negative earnings. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology.

Private Asset Management Inc increased Costco Wholesale Corp (NASDAQ:COST) stake by 3,030 shares to 62,653 valued at $10.29M in 2017Q3. It also upped Verizon Communications (NYSE:VZ) stake by 9,343 shares and now owns 35,542 shares. Cl C was raised too.

Investors sentiment is 0.85 in Q3 2017. Its the same as in 2017Q2. It has no change, as 57 investors sold XOM shares while 806 reduced holdings. only 114 funds opened positions while 621 raised stakes. 2.13 billion shares or 0.48% more from 2.12 billion shares in 2017Q2 were reported. Fulton Breakefield Broenniman Ltd Company holds 0.83% or 57,841 shares in its portfolio. Greatmark Investment Inc invested in 21,945 shares. Cls Invests Ltd Liability Corporation invested 0.03% in Exxon Mobil Corporation (NYSE:XOM). Ashford Cap Management owns 38,647 shares. Moreover, Susquehanna Group Llp has 0.02% invested in Exxon Mobil Corporation (NYSE:XOM) for 423,356 shares. Financial Cap Mgmt Limited has invested 0.29% in Exxon Mobil Corporation (NYSE:XOM). Hennessy Advisors Inc reported 132,060 shares stake. Hirtle Callaghan & Ltd Limited Liability Company invested in 15,700 shares or 0.13% of the stock. Lafleur And Godfrey Limited Liability holds 0.17% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 8,083 shares. Moreover, Fidelity Natl Fincl Inc has 2.43% invested in Exxon Mobil Corporation (NYSE:XOM) for 135,120 shares. Evergreen Capital Management Limited Liability Com owns 36,585 shares. Cannell Peter B stated it has 375,110 shares. Smith Salley Assocs owns 81,692 shares. Chem Comml Bank has invested 1.59% in Exxon Mobil Corporation (NYSE:XOM). Cornerstone Advsrs Inc reported 1.28% stake.

Among 26 analysts covering Exxon Mobil (NYSE:XOM), 9 have Buy rating, 7 Sell and 10 Hold. Therefore 35% are positive. Exxon Mobil has $104 highest and $20 lowest target. $81.39’s average target is 3.88% above currents $78.35 stock price. Exxon Mobil had 88 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Bank of America to “Neutral” on Thursday, June 2. RBC Capital Markets maintained Exxon Mobil Corporation (NYSE:XOM) rating on Monday, October 9. RBC Capital Markets has “Hold” rating and $90.0 target. The firm earned “Hold” rating on Wednesday, August 19 by Citigroup. Jefferies maintained the stock with “Hold” rating in Wednesday, December 20 report. Jefferies maintained the stock with “Hold” rating in Thursday, July 27 report. The firm has “Hold” rating by BMO Capital Markets given on Monday, May 1. The company was upgraded on Monday, June 5 by Scotia Capital. The company was initiated on Friday, March 18 by Nomura. As per Friday, July 21, the company rating was maintained by Citigroup. The company was maintained on Tuesday, January 23 by Piper Jaffray.

Since September 18, 2017, it had 0 insider buys, and 5 selling transactions for $5.23 million activity. Shares for $1.62M were sold by Corson Bradley W. Milton Bryan W also sold $606,082 worth of Exxon Mobil Corporation (NYSE:XOM) on Tuesday, December 12. Chapman Neil A had sold 12,000 shares worth $996,628. Wascom Dennis G had sold 2,412 shares worth $200,293 on Friday, December 15. On Monday, September 18 the insider Franklin Robert Stuart sold $1.81 million.

Perkins Capital Management Inc holds 2.21% of its portfolio in Bovie Medical Corporation for 623,685 shares. Great Point Partners Llc owns 1.83 million shares or 1.2% of their US portfolio. Moreover, Millrace Asset Group Inc. has 1% invested in the company for 315,000 shares. The Washington-based Archon Capital Management Llc has invested 0.14% in the stock. Cortina Asset Management Llc, a Wisconsin-based fund reported 926,666 shares.

Analysts await Bovie Medical Corporation (NYSEAMERICAN:BVX) to report earnings on March, 8. They expect $-0.01 earnings per share, up 75.00% or $0.03 from last year’s $-0.04 per share. After $-0.04 actual earnings per share reported by Bovie Medical Corporation for the previous quarter, Wall Street now forecasts -75.00% EPS growth.